Applying science to care.

Medavera identifies gaps in knowledge and care, methodically researches the subject matter, identifies the top experts to guide the content, and then utilizes a format that will provide the best learning opportunity. We are always looking for new teaching methods and technologies in order to offer stimulating and actionable medical education. Medical education must be meaningful to become applied to clinical practice. Great content, respected leaders, and interesting formats create successful interactions and learning.

New Paradigms in Heart Failure: RAAS Inhibition and the Management of Hyperkalemia

ESC Congress 2015 – London, United Kingdom
Saturday, August 29, 2015

During this live educational program moderated by Professor John McMurray, new options for the treatment of hyperkalemia in heart failure patients will be presented. Dr. Faiez Zannad, a world leader on this topic, will lead the discussion with current challenges in optimizing renin-angiotensin-aldosterone inhibitors (RAASi) and Dr. Ileana Piña will provide pragmatic advice on new pharmacological treatment options for RAASi. This exciting program will offer attendees new ideas for consideration to achieve better outcomes.

Keep up with medical meetings
Download the free app here.
(Reuters) - Express Scripts Holding Co, the largest manager of prescription drug plans for U.S. employers and health plans, said it has reached deals to cover two costly new cholesterol drugs and expects to spend no more than $750 million on them next year.... (Reuters) - Drug distributor AmerisourceBergen Corp agreed to buy PharMEDium Healthcare Holdings Inc for $2.58 billion from private equity firm Clayton, Dubilier & Rice, expanding its business of supplying compounded drugs to hospitals.... DETROIT (Reuters) - Michigan on Tuesday began distributing free water filters to residents of Flint, a week after confirming that some children had elevated levels of lead in their blood since the city began taking water from a nearby river.... (Reuters) - Advaxis Inc said the U.S. Food and Drug Administration has put on hold the mid-stage trials of its experimental cancer drug after a patient died, sending its shares down 27 percent in extended trading.... (Reuters Health) - Traffic pollution near the home – and specifically, benzene in the air - increases the risk of one type of childhood leukemia, according to a nationwide study in France.... (Reuters Health) - Should doctors offer infertility treatment to patients who cross international borders to get care they can’t legally receive in their home country?... SAN FRANCISCO (Reuters) - Nevada has agreed to pay the city of San Francisco $400,000 to settle a lawsuit claiming that the state bused patients, many of them poor and mentally ill, from a Las Vegas hospital to the Bay Area without plans for their care, Governor Brian Sandoval's office said on Tuesday.... (Reuters Health) - For new mothers in the U.S. who receive government-sponsored health insurance, it’s becoming easier to get intrauterine devices (IUDs) implanted immediately after giving birth, a study found.... (Reuters) - Microsoft Corp unveiled on Tuesday its first laptop, a line of Lumia smartphones, a new Surface Pro tablet and an updated version of its wearable fitness tracker, Microsoft Band, all running on Windows 10, its latest operating system.... (Reuters Health) – - The flu vaccine may help prevent flu-related pneumonia, a study suggests.... LITTLE ROCK, Ark. (Reuters) - Planned Parenthood has sought class action status for its Medicaid patients in Arkansas after a U.S. judge ordered the state to continue payments to three women who challenged Arkansas' move to halt payments to the organization.... ZURICH (Reuters) - Swiss drugmaker Roche said final survival data from a Phase III clinical trial showed the Cotellic drug used in combination with Zelboraf helped people with previously untreated BRAF V600 mutation-positive advanced melanoma live significantly longer compared to Zelboraf alone.... DENVER (Reuters) - Two Colorado marijuana users have sued a cannabis grower claiming a "patently dangerous" agricultural fungicide that becomes poisonous when ignited was applied without their knowledge to pot plants they later smoked, court documents showed on Monday.... (Reuters) - The U.S. Food and Drug Administration has ordered three Japanese manufacturers of duodenoscopes to conduct studies to evaluate how the devices are being used, as part of its effort to prevent the transmission of infections through the device.... (Reuters) - The U.S. Food and Drug Administration on Monday approved Alkermes Plc's longer-acting injectable version of blockbuster schizophrenia pill Abilify, making the treatment available in two doses.... SACRAMENTO, Calif. (Reuters) - Physician-assisted suicide will become legal in California under a bill signed into law on Monday by Democratic Governor Jerry Brown, despite intense opposition from some religious and disability rights groups.... (Reuters) - General Mills Inc is recalling 1.8 million boxes of gluten-free Cheerios cereal because they may contain wheat, which can cause adverse reactions in people with gluten allergies.... (Reuters Health) - Medicare Advantage plans might not be meeting the needs of patients requiring the costliest and most complex levels of care, a new study suggests.... (Reuters) - Staff at Sports Direct International Plc, afraid they would be fired for taking sick leave, made more than 80 calls to ambulances from the British company's headquarters over a two-year period, the BBC reported on Monday.... (Reuters) - Staff at Sports Direct International Plc, afraid they would be fired for taking sick leave, made more than 80 calls to ambulances from the British company's headquarters over a two-year period, the BBC reported on Monday....